0001209191-22-015616.txt : 20220303
0001209191-22-015616.hdr.sgml : 20220303
20220303170610
ACCESSION NUMBER: 0001209191-22-015616
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Robinson Byron
CENTRAL INDEX KEY: 0001914899
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40475
FILM NUMBER: 22710099
MAIL ADDRESS:
STREET 1: C/O JANUX THERAPEUTICS, INC.
STREET 2: 11099 N. TORREY PINES ROAD, SUITE 290
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Janux Therapeutics, Inc.
CENTRAL INDEX KEY: 0001817713
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822289112
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11099 TORREY PINES PARK ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-750-4700
MAIL ADDRESS:
STREET 1: 11099 TORREY PINES PARK ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92037
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-01
0
0001817713
Janux Therapeutics, Inc.
JANX
0001914899
Robinson Byron
C/O JANUX THERAPEUTICS, INC.
11099 N. TORREY PINES ROAD, SUITE 290
LA JOLLA
CA
92037
0
1
0
0
Chief Strategy Officer
Stock Option (right to buy)
16.81
2022-03-01
4
A
0
230000
0.00
A
2032-02-29
Common Stock
230000
230000
D
25% of the shares subject to the option vest on February 28, 2023 and the balance will vest in equal monthly installments thereafter over a three year period.
/s/ Maria Dobek, Attorney-in-Fact
2022-03-03